Pam Sharma and Michiel Van Der Heijden discuss neoadjuvant PD(L)1 + CTLA4 inhibition in urothelial cancer.
The Uromigos Bladder Cancer Paper of the Month Kidney Cancer Prostate Cancer Debate ASCO GU Mental Health ADD ESMO 2021 EAU 21 ASCO 21 Microbiome ESMO 2020 COVID-19 ASCO Testis Cancer